JBIO - Jade Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.71
DETAILS
HIGH:
$55.00
LOW:
$40.00
MEDIAN:
$47.00
CONSENSUS:
$46.71
UPSIDE:
118.99%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-25 | Eisner Mark | director | A-Award | 47,675 | $21.81 | $1.0M |
| 2026-06-25 | Eisner Mark | ? | -- | -- | -- | |
| 2026-06-09 | Klein Lawrence Otto | director | A-Award | 34,843 | $15.22 | $530K |
| 2026-06-09 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | 34,843 | $15.22 | $530K |
| 2026-06-09 | DOBMEIER ERIC | director | A-Award | 34,843 | $15.22 | $530K |
| 2026-06-09 | CAIN CHRISTOPHER W. | director | A-Award | 34,843 | $15.22 | $530K |
| 2026-06-09 | Lavelle Erin | director | A-Award | 34,843 | $15.22 | $530K |
| 2026-02-12 | Frohlich Tom | director, officer: Chief Executive Officer | A-Award | 78,750 | -- | -- |
| 2026-02-12 | King Andrew James | officer: See Remarks | A-Award | 41,250 | -- | -- |
| 2026-02-12 | Frohlich Tom | director, officer: Chief Executive Officer | A-Award | 472,500 | $14.81 | $7.0M |
| 2026-02-12 | Balta Elizabeth | officer: See Remarks | A-Award | 28,125 | -- | -- |
| 2026-02-12 | Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 226,875 | $14.81 | $3.4M |
| 2026-02-12 | King Andrew James | officer: See Remarks | A-Award | 247,500 | $14.81 | $3.7M |
| 2026-02-12 | Balta Elizabeth | officer: See Remarks | A-Award | 168,750 | $14.81 | $2.5M |
| 2026-02-12 | Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 37,813 | -- | -- |
| 2025-10-06 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | 1,333,126 | $9.14 | $12.2M |
| 2025-10-06 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | 855,047 | $0.00 | $85 |
| 2025-07-14 | Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 526,000 | $9.00 | $4.7M |
| 2025-07-14 | Dahms Bradford D. | ? | -- | -- | -- | |
| 2025-05-16 | Frohlich Tom | director, officer: Chief Executive Officer | BUY | 6,000 | $7.40 | $44K |
| 2025-04-28 | Fairmount Funds Management LLC | director, 10 percent owner: | ? | 4,935,159 | $0.00 | $493 |
| 2025-04-28 | CAIN CHRISTOPHER W. | ? | -- | -- | -- | |
| 2025-04-28 | Kocinsky Hetal | officer: Chief Medical Officer | ? | 353,533 | $6.03 | $2.1M |
| 2025-04-28 | Lavelle Erin | director | ? | 46,556 | $1.53 | $71K |
| 2025-04-28 | King Andrew James | officer: See Remarks | ? | 27,589 | $0.50 | $14K |